Cell and Gene Therapy Leadership Announcement
Labcorp is pleased to announce the appointment of Maryland Franklin, PhD, as Vice President and Enterprise Head of Cell & Gene Therapy (CGT) for Labcorp’s Drug Development business unit, Covance.
Reduce the time and risk in developing your cell or gene therapy– no matter what stage you’re at.
Assess safety, establish proof of concept and feasibility rapidly
Successfully prepare for regulatory agency meetings and IND/IMPD/CTA submissions
Seamlessly transition to first-in-human trials
Identify, recruit and retain clinical trial participants using data-enabled solutions
Design and conduct patient-centric clinical trials
Prepare and file for BLA/MAA and other submissions
Conduct long term follow up studies, Phase IV trials, and fulfill post-marketing commitments
Test for CMC lot release and stability of manufactured product
Support patient access to your new therapies